The study published in The Lancet showed no therapeutic benefit of empiric TB therapy for patients with HIV.
Study could lead to new drug development targets for forms of anxiety that are more pathological, such as those associated with excessive alcohol intake or opiate abuse.
Buse led a global clinical trial on the new type-2 diabetes drug iDegLira, and he spoke to the local news station about the best ways to screen for the disease.
Conceived and implemented by three experienced nurses at UNC Hospitals, the Labor & Delivery New Nurses Orientation Class utilizes simulation and other hands-on activities to help new nurses build skills and confidence.
North Carolina voters on Tuesday overwhelmingly said yes to the $2 billion Connect NC bond referendum – and to higher education.
The new “smart cell patch” developed at UNC and NC State is a proof of principle to treat millions of people with type-1 and advanced type-2 diabetes.
In the journal Cell Reports, UNC Lineberger researchers reported they found markedly low levels of the protein NLRX1 in multiple laboratory models of colorectal cancer, and in samples of human tissue. Studies have shown that the protein is known to be involved in regulating immune system signals in order to prevent hyperactive inflammatory responses by the immune system, but UNC Lineberger researchers believe their finding also points to a role for the protein in preventing colorectal cancer growth. Based on their findings, they believe they’ve identified a potential treatment for colorectal cancer with low NLRX1.
World Health Organization announced a public health emergency because of Zika in February, a year after the virus was first detected in Brazil.
When Joe Jenkins entered UNC School of Medicine in the 1970s, Berryhill Hall was a new medical education building that fit the times. But more than 40 years later, the building’s limitations – both in size and design – are impediments to overcome for medical students like Krishan Sivaraj.
While efforts to address the issue at UNC continue, a national leader on the subject visited to discuss his research and was welcomed with a full auditorium.
Seven hundred girls from seven cities in Turkey will engage in science, technology, engineering, and math education during a series of three-day conferences.
Findings contradict previous studies questioning the relevance of these cells
Dirk Dittmer, PhD, professor of microbiology and immunology, was selected as one of the American Academy of Microbiology’s 2016 Fellows.
UNC Hospitals’ care earns Blue Distinction® Center+ Designation for Quality and Cost-Efficiency for Five Service Lines
Blue Cross and Blue Shield of North Carolina ranked UNC Hospitals’ bariatric surgery, cardiac care, knee & hip replacement, spine surgery, maternity and complex & rare cancer service lines highly as part of the Blue Distinction Specialty Care program
UNC School of Medicine scientists overcame a significant barrier to convert scar-making fibroblasts into living, beating cardiomyocytes.
Nicoleta Constantin is part of a generation of Romanians that found opportunities outside of Romania after the fall of communism. In her life in the United States, she has performed groundbreaking biochemistry research in the lab of Duke Nobel Prize winner Paul Modrich, but she found her calling when she became a pediatric nurse at North Carolina Children's Hospital.
Researchers from the UNC School of Medicine will present the latest developments in the race to understand the Zika virus at noon on Friday, March 4, in room 2204 of the Medical Biomolecular Research Building.
UNC-led global phase-3 clinical trial sets the stage for improved management of a disease that affects nearly 30 million Americans.
In a first-of-its-kind-study, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center discovered and applied a new screening technique capable of testing thousands of potential drug compounds to see if those compounds can reverse abnormal DNA unwinding in Ewing sarcoma, a bone and soft tissue cancer that’s most common in teens and young adults.
The joint UNC/NC State researcher also earned a grant from JDRF and Sanofi to further develop glucose responsive insulin therapies for diabetes.